当前位置:
X-MOL 学术
›
Ann. Hematol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletion.
Annals of Hematology ( IF 3.0 ) Pub Date : 2020-03-03 , DOI: 10.1007/s00277-020-03975-x Kyoko Yoshihara 1 , Satoshi Yoshihara 1, 2 , Ikuo Matsuda 3 , Takehito Imado 4 , Shohei Matsuo 5 , Masaya Okada 1 , Yoshifumi Shimizu 4 , Seiichi Hirota 3 , Yoshihiro Fujimori 1, 2
中文翻译:
显示在浆母细胞性淋巴瘤和浆母细胞性骨髓瘤之间具有边界点特征的患者的治疗策略,该特征具有17p缺失。
更新日期:2020-03-03
Annals of Hematology ( IF 3.0 ) Pub Date : 2020-03-03 , DOI: 10.1007/s00277-020-03975-x Kyoko Yoshihara 1 , Satoshi Yoshihara 1, 2 , Ikuo Matsuda 3 , Takehito Imado 4 , Shohei Matsuo 5 , Masaya Okada 1 , Yoshifumi Shimizu 4 , Seiichi Hirota 3 , Yoshihiro Fujimori 1, 2
Affiliation
中文翻译:
显示在浆母细胞性淋巴瘤和浆母细胞性骨髓瘤之间具有边界点特征的患者的治疗策略,该特征具有17p缺失。